- Home
- ROIV vs CCCS Comparison
ROIV vs CCCS Comparison
Compare ROIV & CCCS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ROIV
- CCCS
- Stock Information
- Founded
- ROIV 2014
- CCCS 1980
- Country
- ROIV United Kingdom
- CCCS United States
- Employees
- ROIV N/A
- CCCS N/A
- Industry
- ROIV Biotechnology: Pharmaceutical Preparations
- CCCS Computer Software: Prepackaged Software
- Sector
- ROIV Health Care
- CCCS Technology
- Exchange
- ROIV Nasdaq
- CCCS Nasdaq
- Market Cap
- ROIV 8.4B
- CCCS 7.0B
- IPO Year
- ROIV N/A
- CCCS N/A
- Fundamental
- Price
- ROIV $12.30
- CCCS $10.40
- Analyst Decision
- ROIV Strong Buy
- CCCS Strong Buy
- Analyst Count
- ROIV 10
- CCCS 8
- Target Price
- ROIV $17.33
- CCCS $13.88
- AVG Volume (30 Days)
- ROIV 4.2M
- CCCS 2.2M
- Earning Date
- ROIV 08-08-2024
- CCCS 07-30-2024
- Dividend Yield
- ROIV N/A
- CCCS N/A
- EPS Growth
- ROIV N/A
- CCCS N/A
- EPS
- ROIV 5.65
- CCCS 0.03
- Revenue
- ROIV $158,303,000.00
- CCCS $909,603,000.00
- Revenue This Year
- ROIV $45.51
- CCCS $11.07
- Revenue Next Year
- ROIV $42.29
- CCCS $8.60
- P/E Ratio
- ROIV $2.18
- CCCS $301.78
- Revenue Growth
- ROIV 101.44
- CCCS 11.00
- 52 Week Low
- ROIV $8.25
- CCCS $9.79
- 52 Week High
- ROIV $13.24
- CCCS $13.41
- Technical
- Relative Strength Index (RSI)
- ROIV 65.79
- CCCS 40.75
- Support Level
- ROIV $11.50
- CCCS $10.46
- Resistance Level
- ROIV $12.60
- CCCS $11.01
- Average True Range (ATR)
- ROIV 0.35
- CCCS 0.23
- MACD
- ROIV 0.04
- CCCS -0.01
- Stochastic Oscillator
- ROIV 79.19
- CCCS 7.58
About ROIV Roivant Sciences Ltd.
Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.
About CCCS CCC Intelligent Solutions Holdings Inc.
CCC Intelligent Solutions Holdings Inc is a provider of cloud, mobile, AI, telematics, hyperscale technologies and applications for the property and casualty insurance economy. The company's SaaS platform connects trading partners, facilitates commerce, and supports mission-critical, and AI-enabled digital workflows. The company generate revenue through the sale of software subscriptions and other revenue, primarily from professional services. The company has its presence in United States and China. Majority of the revenue is generated from United States.